Positive Pandemic News Lifts Stocks, as Moderna Touts 3-Dose Regimen

The biotech firm says its booster shot gives good protection against Omicron.

In this grim Yuletide season, the mounting COVID-19 case loads and the onset of the Omicron variant have sent the market reeling over the past three trading days. Early trading points to a possible rebound today.

If so, some of the credit goes to news from Moderna that its booster, atop two previous full-dose shots, gives significant protection against the new variant. These glad tidings join a similar upbeat announcement from Pfizer and BioNTech two weeks ago that a third shot of their vaccine also restored protection to a point close to the initial two-dose combo against the original virus. 

Also helping the market is a report from South Africa, where the variant was first identified, that daily infections dropped to the lowest level in two weeks. This gives hope that the new strain’s effect will be short and shallow, and not harm economic activity. 

Never miss a story — sign up for CIO newsletters to stay up-to-date on the latest institutional investment industry news.

Of course, it’s unclear how long the boosters’ effectiveness will last. Moderna also indicated it is getting ready to test an updated vaccine for use against Omicron and other variants. While the S&P 500 was up just under 1% in morning trading, Moderna stock continued to fall, as did that of Pfizer.

And even a three-shot regimen has proved to be, at least in a minority of instances, no shield against the coronavirus. Latest example: CNBC host Jim Cramer said Monday that he has tested positive, with a mild case, even though he had a triple dose of the Moderna vaccine.

Allocator Insights Webinar Dec. 21: Debriefing Tools and Tactics

Four top allocators will vet ideas they’re considering for an evolving investment landscape.


Register now for our discussion on tools and tactics that worked and didn’t in 2021—and how to deal with 2022.

Yes, 2021 has been a charged year for portfolios, as well as allocators. This webinar will vet ideas they’re considering for an evolving investment landscape.

We’ll hear from our illustrious panel of top allocators: Robert “Vince” Smith, chief investment officer at the New Mexico State Investment Council; Charles Van Vleet, CIO of pension investments at Textron; Evril Clayton Jr., deputy director of global equity at the New York State Common Retirement Fund; and Barry Kenneth, CIO at the UK’s Pension Protection Fund.

Our live, virtual discussion will take place on Dec. 21, at 2 p.m. EST.

Want the latest institutional investment industry
news and insights? Sign up for CIO newsletters.

«